(S (NP (NP (DT The) (NN value)) (PP (IN of) (NP (NP (ADJP (NN research) (VBG containing)) (JJ novel) (NNS combinations)) (PP (IN of) (NP (NNS molecules)))))) (VP (MD can) (VP (VB be) (VP (VBN seen) (PP (IN in) (NP (JJ many) (ADJP (ADJP (JJ innovative)) (CC and) (ADJP (NN award) (HYPH -) (VBG winning))) (NN research) (NNS programs)))))) (. .))
(S (PP (IN Despite) (NP (NNS calls) (S (VP (TO to) (VP (VB use) (NP (JJ innovative) (NNS approaches)) (S (VP (TO to) (VP (VB address) (NP (JJ common) (NNS diseases)))))))))) (, ,) (NP (NP (DT an) (VBG increasing) (NN majority)) (PP (IN of) (NP (NN research) (NN funding)))) (VP (VBZ goes) (PP (IN toward) (NP (`` ") (JJ safe) ('' ") (JJ incremental) (NN research)))) (. .))
(S (S (S (VP (VBG Counteracting) (NP (DT this) (NN trend)) (PP (IN by) (S (VP (VBG nurturing) (NP (ADJP (ADJP (JJ novel)) (CC and) (ADJP (RB potentially) (JJ transformative))) (JJ scientific) (NN research))))))) (VP (VBZ is) (ADJP (JJ challenging)))) (, ,) (NP (PRP it)) (VP (MD must) (VP (VB be) (VP (VBN supported) (PP (IN in) (NP (NN competition))) (PP (IN with) (NP (VBN established) (NN research) (NNS programs)))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (NN tool)) (SBAR (WHNP (WDT that)) (S (VP (VBZ helps) (S (VP (TO to) (VP (VB resolve) (NP (NP (DT the) (NN tension)) (PP (IN between) (NP (NP (ADJP (JJ safe) (CC but) (JJ fundable)) (NN research)) (PP (FW vs.) (NP (UCP (NML (JJ high) (HYPH -) (NN risk)) (CC but) (ADJP (RB potentially) (JJ transformational))) (NN research)))))))))))))) (. .))
(S (NP (PRP It)) (VP (VBZ does) (NP (DT this)) (PP (IN by) (S (VP (VBG identifying) (NP (NP (JJ hidden) (VBG overlapping) (NN interest)) (PP (IN around) (NP (JJ novel) (NML (JJ molecular) (NN research)) (NNS topics)))))))) (. .))
(S (ADVP (RB Specifically)) (, ,) (NP (PRP it)) (VP (VBZ identifies) (NP (NP (NNS paths)) (PP (IN of) (NP (NP (JJ molecular) (NNS interactions)) (SBAR (WHNP (WDT that)) (S (VP (VBP connect) (NP (NP (NN research) (NNS topics) (CC and) (NNS hypotheses)) (SBAR (WHNP (WDT that)) (S (VP (MD would) (RB not) (ADVP (RB typically)) (VP (VB be) (VP (VBN associated) (, ,) (PP (IN as) (NP (NP (DT the) (NN basis)) (PP (IN for) (NP (JJ scientific) (NN collaboration)))))))))))))))))) (. .))
(S (SBAR (IN Because) (S (NP (DT these) (NNS collaborations)) (VP (VBP are) (VP (VBN related) (PP (IN to) (NP (NP (DT the) (NNS scientists) (POS ')) (JJ present) (NN trajectory))))))) (, ,) (NP (PRP they)) (VP (VP (VBP are) (NP (JJ low) (NN risk))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN initiated) (ADVP (RB rapidly)))))) (. .))
(S (PP (IN Unlike) (NP (JJS most) (JJ incremental) (NNS steps))) (, ,) (NP (DT these) (NNS collaborations)) (VP (VBP have) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (NNS leaps)) (PP (IN in) (NP (NN understanding)))))) (, ,) (SBAR (IN as) (S (NP (PRP they)) (VP (VBP reposition) (NP (NP (NN research)) (PP (IN for) (NP (JJ novel) (NN disease) (NNS applications)))))))) (. .))
(S (NP (PRP We)) (VP (VBP demonstrate) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT this) (NN tool)))) (S (VP (TO to) (VP (VB identify) (NP (NP (NNS scientists)) (SBAR (WHNP (WP who)) (S (VP (MD could) (VP (VB contribute) (PP (IN to) (S (VP (VBG understanding) (NP (NP (DT the) (JJ cellular) (NN role)) (PP (IN of) (NP (NNS genes)))) (PP (IN with) (NP (NN novel) (NNS associations))) (PP (IN with) (NP (NP (NP (NNP Alzheimer) (POS 's)) (NN disease)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (RB not) (VP (VBN been) (ADVP (RB thoroughly)) (VP (VBN characterized))))))))))) (, ,) (PP (PP (IN in) (NP (NN part))) (IN due) (IN to) (NP (NP (DT the) (NN funding) (NN emphasis)) (PP (IN on) (NP (VBN established) (NN research)))))))))))))) (. .))
